Bicara Therapeutics Inc. (BCAX) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$106.83M | -42.9% |
| 2024 | -$74.75M | -63.8% |
| 2023 | -$45.63M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$106.83M | -42.9% |
| 2024 | -$74.75M | -63.8% |
| 2023 | -$45.63M | — |